Store
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
Publication Date: October 27, 2023
Tags: AMEA, APAC, China, Coagulation, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), India, Infectious Diseases, Latin America, Middle East, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 75
SKU: 23-701
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key Features:
- Comprehensive coverage of 30 countries, including Latin America, the Middle East, APAC, and Eastern Europe
- Reliable estimates from an IVD-focused analyst team, authors of Kalorama’s renowned Worldwide Market for In Vitro Diagnostics report
- Sizing for 19 important IVD market segments, including lab-based and point-of-care (POC) segments for various disease areas
- Forecasts in revenue up to 2028 for each segment, with compound annual growth rates (CAGRs) provided
- Quarterly updates (4 annually in 2023) to reflect market changes, ensuring the latest data for informed decision-making
- Analyst notes highlighting significant developments in the industry
- Definitions and descriptions of tests for better understanding
- Over 2800 data points offering comprehensive market insights
Why Choose the IVD Market Atlas:
- One report covering 30 countries, saving the need to purchase multiple individual country reports
- Aligned with Kalorama’s expert global estimates, providing consistent and reliable market data
- Includes major IVD segments forecasted over five years, offering a holistic view of the market
Market Segments Covered:
- Blood Bank Immunoassays
- Blood Bank Molecular (NAT)
- Clinical Chemistry
- Coagulation
- COVID-19
- Critical Care
- FOB
- Glucose
- Hematology
- Histology/Cytology
- ID/AST Microbiology
- Immunoassays
- Immunoassays, Micro
- Molecular, Micro
- Molecular, Others
- Overall Country IVD
- Point of Care
- POC Infectious Disease
- Pregnancy Testing
Subscribe for Quarterly Updates:
Subscribers will receive quarterly updates via Kalorama’s Knowledge Center product, ensuring they always have the latest data for their business planning needs. Stay ahead of market changes and make informed decisions with Kalorama’s 30 Country IVD Market Atlas.
Table: Japan IVD Market by Segment, Estimated 2023-2028 (in millions $)
| Segment | 2023 | 2028 | CAGR |
| General Chemistries | $XX Million | $XX Million | XX% |
| Critical Care (core lab) | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Coagulation PT/Routine | $XX Million | $XX Million | XX% |
| Immunoassays – Micro | $XX Million | $XX Million | XX% |
| Immunoassays – Non-Micro | $XX Million | $XX Million | XX% |
| Blood Bank Screening – Immunos | $XX Million | $XX Million | XX% |
| Microbiology – ID/AST | $XX Million | $XX Million | XX% |
| Molecular Respiratory | $XX Million | $XX Million | XX% |
| Molecular Bloodstream/HAI | $XX Million | $XX Million | XX% |
| Molecular HIV & Hepatitis | $XX Million | $XX Million | XX% |
| Molecular – Other (blood screening, STDs, and other microbiology) | $XX Million | $XX Million | XX% |
| POC Glucose (all) | $XX Million | $XX Million | XX% |
| POC Critical Care | $XX Million | $XX Million | XX% |
| POC Infectious Disease (all) | $XX Million | $XX Million | XX% |
| POC Pregnancy & Fertility | $XX Million | $XX Million | XX% |
| POC Fecal Occult | $XX Million | $XX Million | XX% |
| Other POC | $XX Million | $XX Million | XX% |
| Histology | $XX Million | $XX Million | XX% |
| Other IVD | $XX Million | $XX Million | XX% |
| Total Japan IVD Market | $XX Million | $XX Million | XX% |
| SARS-Cov-2 (COVID-19) Market* | $XX Million | $XX Million | XX% |
*Extracted from Immunoassay, Molecular and POC Infectious Disease Markets
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter One: Worldwide IVD Market
IVD Market Demand and Growth
Scope and Methodology
Market Segmentation
Country Atlas Scope
- Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2023
Chapter Two: United States
U.S. IVD Market Overview
- Table 2-1: U.S. IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Three: Germany
Germany IVD Market Overview
- Table 3-1: Germany IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Four: Japan
Japan IVD Market Overview
- Table 4-1: Japan IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Five: China
China IVD Market Overview
- Table 5-1: China IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Six: France
France IVD Market Overview
- Table 6-1: France IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Seven: United Kingdom
United Kingdom IVD Market Overview
- Table 7-1: United Kingdom IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eight: Italy
Italy IVD Market Overview
- Table 8-1: Italy IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Nine: Canada
Canada IVD Market Overview
- Table 9-1: Canada IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Ten: Spain
Spain IVD Market Overview
- Table 10-1: Spain IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eleven: Australia
Australia IVD Market Overview
- Table 11-1: Australia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twelve: Brazil
Brazil IVD Market Overview
- Table 12-1: Brazil IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirteen: Russia
Russia IVD Market Overview
- Table 13-1: Russia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Fourteen: India
India IVD Market Overview
- Table 14-1: India IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Fifteen: Switzerland
Switzerland IVD Market Overview
- Table 15-1: Switzerland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Sixteen: Netherlands
Netherlands IVD Market Overview
- Table 16-1: Netherlands IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Seventeen: Poland
Poland IVD Market Overview
- Table 17-1: Poland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eighteen: Turkey
Turkey IVD Market Overview
- Table 18-1: Turkey IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Nineteen: Sweden
Sweden IVD Market Overview
- Table 19-1: Sweden IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty: Belgium
Belgium IVD Market Overview
- Table 20-1: Belgium IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-One: Mexico
Mexico IVD Market Overview
- Table 21-1: Mexico IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Two: Austria
Austria IVD Market Overview
- Table 22-1: Austria IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Three: Saudi Arabia
Saudi Arabia IVD Market Overview
- Table 23-1: Saudi Arabia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Four: South Korea
South Korea IVD Market Overview
- Table 24-1: South Korea IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Five: Romania
Romania IVD Market Overview
- Table 25-1: Romania IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Six: Egypt
Egypt IVD Market Overview
- Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Seven: Indonesia
Indonesia IVD Market Overview
- Table 27-1: Indonesia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Eight: Chile
Chile IVD Market Overview
- Table 28-1: Chile IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Nine: South Africa
South Africa IVD Market Overview
- Table 29-1: South Africa IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirty: United Arab Emirates
United Arab Emirates IVD Overview
- Table 30-1: United Arab Emirates IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirty-One: Vietnam
Vietnam IVD Market Overview
- Table 31-1: Vietnam IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Related products
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
Price range: $5,000.00 through $7,500.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
Price range: $5,000.00 through $7,875.00
The IVD Market in South Korea, 2024
February 26, 2024
Gain valuable insights into South Korea’s in vitro diagnostics (IVD) market with Kalorama Information’s comprehensive report, The IVD Market in South Korea, 2024. We offer a detailed analysis of South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into key categories such as clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC),…
Price range: $5,000.00 through $7,875.00
